The Patent Finder

N30 Pharmaceuticals, LLC

Also on record
Records under this name other than patents N30 Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to N30 Pharmaceuticals, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,921,562Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,673,961Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Formerly held
Lapsed on the fee record
Ended Mar 18, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 18, 2026USPTO record
US 9,856,219Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Formerly held
Lapsed on the fee record
Ended Jan 2, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 2, 2026USPTO record
US 9,814,700Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Formerly held
Lapsed on the fee record
Ended Nov 14, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 14, 2025USPTO record
US 9,498,466Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Formerly held
Lapsed on the fee record
Ended Nov 22, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2024USPTO record
US 9,433,618Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Formerly held
Lapsed on the fee record
Ended Sep 6, 2024 · USPTO record
Lapsed on the fee recordEnded Sep 6, 2024USPTO record
US 9,315,462Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Formerly held
Lapsed on the fee record
Ended Apr 19, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 19, 2024USPTO record
US 9,180,119Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Formerly held
Lapsed on the fee record
Ended Nov 10, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 10, 2023USPTO record
US 9,139,528Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
Formerly held
Lapsed on the fee record
Ended Sep 22, 2023 · USPTO record
Lapsed on the fee recordEnded Sep 22, 2023USPTO record
US 8,957,105Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
Formerly held
Lapsed on the fee record
Ended Feb 17, 2023 · USPTO record
Lapsed on the fee recordEnded Feb 17, 2023USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited